Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Athena Global Technologies Ltd

ATHENAGLO
BSE
72.03
0.77%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Athena Global Technologies Ltd

ATHENAGLO
BSE
72.03
0.77%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
101Cr
Close
Close Price
72.03
Industry
Industry
IT - Software
PE
Price To Earnings
PS
Price To Sales
9.47
Revenue
Revenue
11Cr
Rev Gr TTM
Revenue Growth TTM
-35.80%
PAT Gr TTM
PAT Growth TTM
-107.93%
Peer Comparison
How does ATHENAGLO stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
ATHENAGLO
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
233444443332
Growth YoY
Revenue Growth YoY%
-58.1-29.539.018.988.523.772.75.8-26.3-27.6-41.2-47.3
Expenses
ExpensesCr
8746176547469
Operating Profit
Operating ProfitCr
-6-4-2-2-13-2-10-4-1-4-7
OPM
OPM%
-283.2-104.2-60.5-55.0-331.9-51.8-19.2-0.7-145.3-46.4-138.1-304.1
Other Income
Other IncomeCr
000023600000024
Interest Expense
Interest ExpenseCr
233323343337
Depreciation
DepreciationCr
0000-10000000
PBT
PBTCr
-8-6-4-6222-5-4-4-7-4-69
Tax
TaxCr
001-210100008
PAT
PATCr
-8-6-5-4221-5-5-4-7-4-61
Growth YoY
PAT Growth YoY%
-165.0-106.335.1-15.33,041.323.28.48.8-103.18.4-35.8129.7
NPM
NPM%
-360.6-183.1-202.4-106.35,627.6-113.7-107.3-91.7-238.1-143.7-247.951.6
EPS
EPS
-5.6-4.6-3.8-2.7164.9-3.4-3.3-2.7-4.9-3.1-4.40.8

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2014Mar 2015Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
681181426262012141611
Growth
Revenue Growth%
18.0-24.577.286.7-1.3-22.8-40.314.713.4-31.6
Expenses
ExpensesCr
12714111426282827342327
Operating Profit
Operating ProfitCr
-51-3-300-2-8-15-20-7-16
OPM
OPM%
-84.59.7-31.2-33.0-1.40.9-6.5-37.9-128.1-147.6-46.3-148.5
Other Income
Other IncomeCr
001422291237124
Interest Expense
Interest ExpenseCr
001123397101216
Depreciation
DepreciationCr
000004301011
PBT
PBTCr
-61-30-1-4-5-8-23206-19-9
Tax
TaxCr
00001110-1118
PAT
PATCr
-61-30-1-6-6-8-22205-20-16
Growth
PAT Growth%
110.0109.7-479.2-353.0-12.6-24.9-173.01,030.7-109.818.3
NPM
NPM%
-87.87.5-32.44.2-8.9-21.7-24.8-40.1-183.31,488.0-128.9-153.9
EPS
EPS
-7.00.7-3.10.3-1.1-3.8-5.7-6.2-16.5153.3-14.3-11.6

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2014Mar 2015Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
8810111111121313141415
Reserves
ReservesCr
-17-17-21-20-21-23-7-5-24185165130
Current Liabilities
Current LiabilitiesCr
99131112192725235895114
Non Current Liabilities
Non Current LiabilitiesCr
161612192627254482686761
Total Liabilities
Total LiabilitiesCr
151614233034587795325341320
Current Assets
Current AssetsCr
896101215151724161923
Non Current Assets
Non Current AssetsCr
778131718446071309322296
Total Assets
Total AssetsCr
151614233034587795325341320

Cash Flow

Consolidated
Standalone
Financial YearMar 2014Mar 2015Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
3005-195-4-211210
Investing Cash Flow
Investing Cash FlowCr
-40-2-3-3-10-7-9-13-5-4
Financing Cash Flow
Financing Cash FlowCr
101-14211235-8-5
Net Cash Flow
Net Cash FlowCr
0001-110-12-10
Free Cash Flow
Free Cash FlowCr
20-25-255-7-211210
CFO To PAT
CFO To PAT%
-46.71.8-2.81,428.094.3-155.8-84.351.394.25.8-47.7
CFO To EBITDA
CFO To EBITDA%
-48.51.4-2.9-181.3605.43,825.0-323.754.3134.8-58.0-132.9

Ratios

Consolidated
Standalone
Financial YearMar 2014Mar 2015Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
8626165141429267126128
Price To Earnings
Price To Earnings
0.011.10.042.60.00.00.00.00.00.60.0
Price To Sales
Price To Sales
1.20.82.52.03.61.61.64.65.69.28.2
Price To Book
Price To Book
-0.8-0.7-2.4-1.7-5.5-3.67.911.3-6.50.60.7
EV To EBITDA
EV To EBITDA
-2.011.9-9.0-7.0-269.5195.7-30.0-17.9-9.1-10.4-31.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
100.0100.0100.0100.0100.0100.087.775.457.375.592.6
OPM
OPM%
-84.59.7-31.2-33.0-1.40.9-6.5-37.9-128.1-147.6-46.3
NPM
NPM%
-87.87.5-32.44.2-8.9-21.7-24.8-40.1-183.31,488.0-128.9
ROCE
ROCE%
86.2-9.338.1-23.2-21.414.9-13.32.0-24.775.8-2.6
ROE
ROE%
58.6-6.231.9-3.513.750.5-121.7-100.0214.4103.2-11.3
ROA
ROA%
-37.53.6-24.21.5-4.3-17.0-11.1-10.4-23.263.1-5.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Athena Global Technologies Limited (AGTL) is a Hyderabad-based diversified enterprise with a strategic footprint in the **USA** and **UK**. The company operates a multi-driver growth model, leveraging its core competencies in software development and digital transformation to scale high-growth subsidiaries in the **EdTech**, **HealthTech**, and **Commercial Real Estate** sectors. --- ### **Core Technical Competencies & Digital Pillars** AGTL positions itself as a provider of "smart, autonomous decision-making" systems. The company underwent a brand refresh in **August 2024** to reflect this shift toward AI-driven, digital-first service delivery. | Service Category | Key Offerings & Technologies | | :--- | :--- | | **AI & Cognitive** | Real-time customer interactions, **virtual predictive/diagnostic applications**, and cognitive automation. | | **Automation & Robotics** | **Robotic Process Automation (RPA)**, Chatbots, and Voicebots across all device ecosystems. | | **Data Science** | Actionable intelligence models and data analytics for operational efficiency. | | **Emerging Tech** | **Blockchain** ("Internet of Value") and **IoT-based solutions** for customer engagement. | | **Software Engineering** | Product Engineering, **QA & Testing** (acting as production environment custodians), and Cloud-native development. | --- ### **Diversified Business Segments & Subsidiary Ecosystem** The Group’s operations are categorized into six primary reporting segments, executed through specialized subsidiaries: * **Software Services:** Core IT activities including development, maintenance, consulting, and QA. This segment reported a **21.7%** year-on-year growth as of late 2024. * **MedleyMed (HealthTech):** Operates an **Online Pharmacy Platform** and **Online Trade of Pharma**. It provides B2B and B2C medicine delivery, telemedicine, and pharmacy logistics. AGTL recently acquired **100%** of **Medleymed Healthcare Solutions Private Limited** and established **MedleyMed, Inc.** in the **USA**. * **Tutoroot (EdTech):** A wholly owned subsidiary providing **Online Education Services**. It focuses on personalized learning for K-12, university programs, and **competitive examinations** in India and abroad. * **Real Estate & Leasing:** Revenue derived from the sale and lease of residential and commercial units. The cornerstone of this segment is the **Phoenix Centaurus Project** in Hyderabad’s Financial District. --- ### **Strategic Asset: The Phoenix Centaurus Project** AGTL holds a significant stake in a major commercial real estate asset that serves as a primary vehicle for debt servicing and liquidity: * **Ownership:** AGTL holds a **~5 lakh sq. ft.** share in this **~21 lakh sq. ft.** project (a 5-acre joint development with Phoenix Tech Zone). * **Key Tenant:** In July 2025, the company leased **125,048.98 sq. ft.** (the entire 16th floor) to **FedEx Express**. * **Valuation:** Following the completion of the Manikonda project, the company recognized buildings under investment property at a fair value of **₹239 crore**, resulting in a one-time "Other Income" increase of **₹235.94 crore** in FY25. * **Monetization:** The company has approved the sale or lease of up to **1,50,000 Sq. Ft.** of this SEZ property to fund operations and debt obligations. --- ### **Financial Performance & Capital Structure** The company demonstrated a massive turnaround in **FY 2023-24**, though liquidity remains a point of scrutiny. **Consolidated Financial Highlights:** | Metric (₹ in Crore) | FY 2023-24 | FY 2022-23 | | :--- | :--- | :--- | | **Total Income** | **250.35** | **12.60** | | **Net Profit / (Loss)** | **205.10** | **(22.03)** | | **Revenue from Operations** | **9.71** | **9.80** | | **Foreign Exchange Earnings** | **8.18** | **6.87** | **Capital Raising & Restructuring:** To manage working capital and debt, the company has utilized several instruments: * **Convertible Warrants:** Issued **7,00,000** warrants at **₹84** (Apr 2026), **6,50,000** warrants at **₹87** (Feb 2024), and **6,70,000** warrants at **₹59** (May 2023) to the Promoter Group. * **Borrowing Limits:** Increased to **₹350 Crores** to support expansion. * **Equity Status:** **94.03%** of equity shares are dematerialized (**ISIN: INE576B01019**). --- ### **Debt Profile & Liquidity Status** As of December 2024, liquidity was characterized as **Poor** due to a negative EBITDA of **₹13.18 crore** against interest obligations of **₹11.00 crore** for FY24. * **Non-Current Borrowings:** Reduced to **₹57.88 Crore** (March 2024) from **₹66.26 Crore** (March 2023). * **Secured Loans:** **₹52.86 Crore** hypothecated against the 15th and 16th floors of the Centaurus complex, held with **Axis Finance** and **Aditya Birla Finance**. * **NCD Withdrawal:** In **March 2025**, AGTL voluntarily withdrew a proposed **₹150 crore** NCD issue after failing to meet sanction letter conditions, leading to the withdrawal of its **IVR C/Stable** rating. * **Related Party Loans:** As of Sep 2025, AGTL has extended **₹14.44 Crore** to Medley Medical and **₹6.85 Crore** to Tutoroot. --- ### **Risk Matrix & Mitigation Strategies** | Risk Category | Primary Exposure & Impact | | :--- | :--- | | **Debt Servicing** | Ongoing **delays and irregularities** in servicing obligations; risk of lenders calling loans if covenants are breached. | | **Market Concentration** | Over **90%** of projected medium-term revenue is derived from **export markets** (Healthcare/Finance). | | **Competitive Pressure** | High pricing pressure from larger, well-capitalized IT service providers. | | **Real Estate Cyclicality** | Volatility in leasing revenues and dependence on asset monetization for liquidity. | | **Human Capital** | High demand for digital skills makes talent acquisition and retention a critical challenge. | | **Financial Risks** | Exposure to **Foreign Exchange** fluctuations and **Salary Inflation** impacting defined benefit obligations. | ### **Future Outlook** AGTL is prioritizing **innovation-led differentiation** and **operational efficiency** to return to sustainable profitability. The strategy hinges on: 1. **Asset Monetization:** Utilizing the **Centaurus SEZ** to deleverage the balance sheet. 2. **Niche Verticals:** Tailoring AI and Blockchain solutions for **Fintech, Logistics, and Healthcare**. 3. **Global Expansion:** Scaling the **MedleyMed** platform in the US market and expanding **Tutoroot’s** digital training reach.